Class I/II Obesity
The goal of this clinical trial is to learn about the nature of brain abnormalities associated with excess body fat in h…
Montreal, CanadaEst. completion Dec 1, 2028
Overweight and Obesity
The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending dose…
Phoenix, United StatesEst. completion Dec 2027
Obesity & Overweight
The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devi…
Phoenix, United StatesEst. completion Nov 30, 2026
Metabolic DiseaseObesityLi-Fraumeni SyndromeCardiomyopathyAtherosclerosisInflammatory Disease
Background:
\- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory o…
Washington D.C., United States
Overweight , ObesityAdults
A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have pr…
Birmingham, United StatesEst. completion Aug 24, 2027
Overweight or Obesity
This study will test an experimental drug called olatorepatide ("study drug") to determine how safe and effective this d…
Mobile, United StatesEst. completion Jan 21, 2028
Diabetes MellitusObesityFatty Liver
Background:
Children s weight has increased sharply in recent years. This may put them at higher risk for health proble…
Phoenix, United StatesEst. completion Dec 31, 2041
Obesity
Background
Obesity and physical inactivity contribute substantially to cardiovascular disease risk, diabetes, hypertens…
Bethesda, United StatesEst. completion Aug 4, 2027
Obesity & Overweight
The purpose of this study is to investigate whether lifestyle factors can alter gut barrier integrity and whether disrup…
Hellerup, DenmarkEst. completion Aug 10, 2027
Overweight and/or ObesityMetabolic SyndromeNonalcoholic Fatty Liver Disease
This randomized, sham-controlled trial evaluates the efficacy and safety of ERCG plus optimized lifestyle intervention c…
Beijing, ChinaEst. completion Mar 30, 2027
High Blood SugarHigh Blood PressureOverweight and Obesity
Bioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides …
Edmonton, CanadaEst. completion Jan 2027
Quality of Life (QOL)NutritionPhysical ActivityObesityChildhood Obesity
The goal of this interventional study is to prevent childhood obesity in children aged 6-12 years in Chiba City, Japan. …
Chiba, JapanEst. completion Sep 2027
Chronic Weight Management
This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is de…
San Antonio, United StatesEst. completion Jun 2027
ObeseOverweight
This study is the first time SA030 is being given to people. The goal is to understand how safe it is, how well it is to…
Brisbane, AustraliaEst. completion Apr 24, 2028
Overweight or Obesity
To evaluate the safety and tolerability of single dose and multiple doses of SYH2082 Injection in healthy participants.
Nedlands, AustraliaEst. completion Jan 30, 2027
Obesity, ChildhoodInsulin Resistance
This is a 12-month, single center, three-arm parallel design, double-blind, randomized clinical trial, to compare the ef…
Edmonton, CanadaEst. completion Feb 2027
Type 1 DiabetesOverweight , Obesity
The goal of this 24 week double-blinded, randomized, parallel controlled clinical trial is to learn how semaglutide affe…
Montreal, CanadaEst. completion Sep 1, 2028
Obesity or Overweight
Efficacy, safety and tolerability of switching from GLP-1RA to maridebart cafraglutide in adults with obesity or overwei…
Pelham, United StatesEst. completion Jan 3, 2028
Chronic Weight Management
This is a randomized, placebo-controlled, double-blind, single and multiple ascending dose study to evaluate the safety,…
South Miami, United StatesEst. completion Apr 2027
Obesity (BMI Equal to or >30)Immune FunctionHDLGut MicrobiomeHealthy Adult Participants
The purpose of this intervention study is to investigate the effects of daily egg intake on markers of gut health, high-…
Storrs, United StatesEst. completion Dec 31, 2027